Sort
21,281 grants matching “influenza”
Novel Formulation of Flu Vaccine for the Aged
$298,738Jiu Jiang · Dmx, Inc. · R43 · FY2012 · AG
Strain-Independent Therapeutic Antibodies for Influenza
$298,735Lawrence Michael Kauvar · Trellis Bioscience, Inc. · R44 · FY2014 · AI
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
$298,722Erica D Dawson · Indevr, Inc. · R43 · FY2008 · AI
Viral and Host cDNA Libraries from 1918 Influenza Cases
$298,698Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AI
A biophysical assay targeting SARS CoV-2 RNA
$298,689Sandra Paige Story · Nubad, Llc · R43 · FY2023 · AI
Pivotal role of VLA-1 in CD8 T cell retention & survival
$298,677David James Topham · University Of Rochester · R01 · FY2007 · AG
Design and Optimization of Clinical Gene Gun for Delivery of Nucleic Acid Vaccines
$298,613Kristyn Rene Aalto · Orlance, Inc. · R43 · FY2019 · AI
Bioinformatics Core
$298,599Purveshkumar Khatri · Stanford University · U19 · FY2019 · AI
Mechanisms of STING-Mediated Mucosal Vaccine Adjuvant Activity of Cyclic di-GMP
$298,587Lei Jin · University Of Florida · R01 · FY2017 · AI
Simulation of Proton Translocation in Biomolecules
$298,584Gregory A. Voth · University Of Chicago · R01 · FY2015 · GM
Development of a Tetravalent Dengue Vaccine that Links Innate and Adaptive Immuni
$298,530Albert Price · Vaxinnate Corporation · R43 · FY2007 · AI
Microbiological Characterization and Mitigation of Bioaerosols in CAFOs
$298,528Norman R Pace · University Of Colorado · R01 · FY2009 · OH
Novel therapeutic monoclonal antibody targeting SP-R210 isoforms to prevent influenza disease progression and expedite resolution of comorbidities
$298,498Andy Agrawal · Respana Therapeutics, Inc. · R41 · FY2018 · AI
Synthetic Nanoparticle based Universal Influenza Vaccine
$298,492Ramila Philip · Immunotope, Inc. · R43 · FY2011 · AI
Niclosamide Formulations for the Treatment of Influenza Infections
$298,479Gary Fujii · Molecular Express, Inc. · R43 · FY2022 · AI
Regulation of B Lymphocyte Defects in Senescent Humans
$298,466Bonnie B. Blomberg · University Of Miami School Of Medicine · R01 · FY2011 · AG
Regulation of B Lymphocyte Defects in Senescent Humans
$298,466Bonnie B. Blomberg · University Of Miami School Of Medicine · R01 · FY2012 · AG
Use of Spray-Drying as a Manufacturing Process for Oral Adenovirus Vaccine
$298,464Amish Patel · Paxvax, Inc. · R43 · FY2012 · GM
Mechanisms of STING-Mediated Mucosal Vaccine Adjuvant Activity of Cyclic di-GMP
$298,442Lei Jin · University Of Florida · R01 · FY2019 · AI
Analysis of Novel Virus-Induced RNAs
$298,427Curt M Horvath · Northwestern University · R01 · FY2018 · GM
STRATEGIES FOR IMPROVING RAPID INFLUENZA TESTING IN AMBULATORY SETTING (SIRAS)
$298,417Nancy Jean Kupka · Joint Commission · U47 · FY2012 · CD
STRATEGIES FOR IMPROVING RAPID INFLUENZA TESTING IN AMBULATORY SETTING (SIRAS)
$298,417Nancy Jean Kupka · Joint Commission · U47 · FY2011 · CD
SIMULTANEOUS SCREENING FOR A/H3N2, A/H1N1, A/H5N1 AND B INFLUENZA VIRUSES
$298,406Erica D Dawson · Indevr, Inc. · R43 · FY2009 · AI
Improved Vaccines for Influenza B Virus
$298,391Robert Gerald Whalen · Altravax, Inc. · R43 · FY2010 · AI
OPUS: SYNTHESIZING THEORY AND DATA IN THE ECOLOGY OF ZOONOTIC DISEASES: A MULTI-SYSTEM PERSPECTIVE
$298,354John M Drake · University Of Georgia Research Foundation Inc · · FY2025 · BIO